Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol management in theory and practice

A M Gotto1

  • 1Cornell University Medical College, New York, NY 10021, USA. dean@mail.med.cornell.edu

Circulation
|January 7, 1998
PubMed
Summary

Aggressive lipid modification is crucial for preventing coronary heart disease (CHD). Despite evidence, this treatment is underused in at-risk patients, necessitating improved clinical implementation and education.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma lipids and other cardiovascular risk factors in Costa Rican adolescents.

Revista panamericana de salud publica = Pan American journal of public health·2001
Same author

Therapeutic impact of statin therapy in patients with low HDL cholesterol.

Current atherosclerosis reports·2000
Same author

Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group.

The American journal of cardiology·2000
Same author

Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.

Journal of the American College of Cardiology·2000
Same author

Risk reduction.

Circulation·2000
Same author

Case 1: a patient with elevated low-density lipoprotein cholesterol.

The American journal of cardiology·2000

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Coronary heart disease (CHD) remains a leading cause of death in the US.
  • Evidence strongly supports aggressive lipid modification for CHD risk reduction.
  • Current clinical practice shows underimplementation of proven lipid-lowering strategies, particularly in patients with existing CHD.

Purpose of the Study:

  • To review the clinical and mechanistic understanding of aggressive lipid management benefits.
  • To highlight recent findings and their clinical implications for CHD prevention.
  • To emphasize the need for education and reinforcement of existing recommendations.

Main Methods:

  • Review of current clinical evidence on lipid modification.
  • Analysis of mechanistic understanding of lipid-lowering therapies.
  • Synthesis of recent findings and their impact on clinical practice.

Main Results:

  • Growing public awareness of cholesterol as a modifiable CHD risk factor.
  • Recommendations for earlier and more aggressive intervention in patients with existing disease.
  • Discussion of the cost-effectiveness of lipid-regulating therapy.

Conclusions:

  • Despite declining CHD rates, continued focus on primary and secondary prevention is imperative.
  • Education and reinforcement of guidelines are necessary to improve clinical implementation of lipid modification.
  • Aggressive lipid management is a proven strategy that must be more widely adopted.

Related Experiment Videos